Showing results (1051-1060 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|February 21, 2012
Bacteria and their toxins tamed for immunotherapyIrena Adkins, Jana Holubova, Martina Kosova, et al.Current Pharmaceutical Biotechnology|February 21, 2012
Current immunotherapy of multiple sclerosis and future challenges: relevance of immune-mediated repairMichael D CarrithersCurrent Pharmaceutical Biotechnology|February 21, 2012
Infections in patients with rheumatic diseases treated with TNF antagonistsBeatriz Pérez-Zafrilla, Loreto Carmona, Juan J Gómez-ReinoCurrent Pharmaceutical Biotechnology|January 3, 2012
Autoantibodies and Sjögren's syndrome: a physiologist's perspectivePeter M Smith, Luke J DawsonCurrent Pharmaceutical Biotechnology|January 3, 2012
Primary Sjögren's syndrome and the type I interferon systemGunnel Nordmark, Maija-Leena Eloranta, Lars RonnblomCurrent Pharmaceutical Biotechnology|January 19, 2012
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic targetElisabetta Botti, Giulia Spallone, Roberta Caruso, et al.Current Pharmaceutical Biotechnology|January 19, 2012
Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseasesLoredana Frasca, Roberto LandeCurrent Pharmaceutical Biotechnology|January 19, 2012
New pharmaceutical concepts for sebaceous gland diseases: implementing today's pre-clinical data into tomorrow's daily clinical practiceVasiliki A Zampeli, Evgenia Makrantonaki, Thrasivoulos Tzellos, et al.Current Pharmaceutical Biotechnology|November 30, 2011
Non-alcoholic steatohepatitis: new insights from OMICS studiesCecile Martel, Davide Degli Esposti, Antonin Bouchet, et al.Current Pharmaceutical Biotechnology|November 30, 2011
Application of lipidomics to assess lipogenesis in drug development and pre-clinical trialsAntonin Lamaziere, Claude Wolf, Peter J QuinnPageof 303